Darbepoetin alfa administered every 3 weeks alleviates anaemia in patients with solid tumours receiving chemotherapy; results of a double-blind, placebo-controlled, randomised study

By Kotasek D.   Steger G.   Faught W.   Underhill C.   Poulsen E.   Colowick A.B.   Rossi G.   Mackey J.   for the AranespTM 980291 Study Group  

European Journal of Cancer, Vol. 39, Iss. 14, 2003-09 ,pp. : 2026-2034

Elsevier

Access to resources Recommend Favorite

Comparative evaluation of thrombocytopenia in adult patients receiving linezolid or glycopeptides in a respiratory intensive care unit

By          

Experimental and Therapeutic Medicine, Vol. 7, Iss. 2, 2014-01 ,pp. : 501-507

Spandidos Publications

Access to resources Recommend Favorite

Granulocyte-macrophage Colony-stimulating Factor Improves Immunological Parameters in Patients with Refractory Solid Tumours Receiving Second-line Chemotherapy: Correlation with Clinical Responses

By Baxevanis C.N.   Tsavaris N.B.   Papadhimitriou S.I.   Zarkadis I.K.   Papadopoulos N.G.   Bastounis E.A.   Papamichail M.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1202-1208

Elsevier

Access to resources Recommend Favorite

Single agents should be administered in preference to combination chemotherapy for the treatment of patients over 70 years of age with advanced ovarian carcinoma

By Pignata S.   Monfardini S.  

European Journal of Cancer, Vol. 36, Iss. 7, 2000-05 ,pp. : 817-820

Elsevier

Access to resources Recommend Favorite

Prognostic factors in patients with colorectal cancer receiving adjuvant chemotherapy or chemoradiotherapy: A pooled analysis of two randomized studies

By Bamias Aristotle   Basdanis George   Xanthakis Ioannis   Pavlidis Nicholas   Fountzilas George  

International Journal of Gastrointestinal Cancer, Vol. 36, Iss. 1, 2005-08 ,pp. : 29-38

Humana Press, Inc

Access to resources Recommend Favorite